Form 4: GE HealthCare Director Phoebe Yang Granted Restricted Stock Units

GE HealthCare Technologies Inc. Director Phoebe L. Yang received an award of 3,092 restricted stock units, increasing her total beneficial ownership to 9,116 shares of common stock.

Summary

• Phoebe L. Yang, a Director of GE HealthCare Technologies Inc. (GEHC), was granted 3,092 restricted stock units (RSUs) on May 28, 2025.
• Each RSU represents the right to receive one share of GE HealthCare common stock.
• Following this transaction, Ms. Yang's total beneficial ownership of GE HealthCare common stock increased to 9,116 shares.
• The RSUs will vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Settlement of vested RSUs may be deferred by Ms. Yang in accordance with the company's Non-Employee Director Compensation and Benefits Plan.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates alignment of director interests with shareholders through equity compensation, a standard and generally well-regarded practice.

Positives

• The award of restricted stock units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The increase in beneficial ownership by a director demonstrates continued confidence in the company's future prospects.

Future Outlook

The future outlook for the reporting person includes the vesting of 3,092 restricted stock units by May 28, 2026, or earlier, which will convert into shares of GE HealthCare common stock, potentially increasing her direct shareholding.

Industry Context

This Form 4 filing represents a routine insider transaction related to director compensation, which is a common practice across publicly traded companies in the healthcare technology sector to incentivize and align the interests of non-employee directors with shareholders.

Stakeholder Impact

• Shareholders: The equity award aligns the director's financial interests with shareholder value creation, potentially leading to more focused governance.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Vesting of the 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Potential deferral of settlement of vested restricted stock units by the reporting person.

Key Dates

Keywords

GE HealthCare Technologies Inc., GEHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Phoebe L. Yang, Equity Award